Search Results - "Zlotta, A R"

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer by Miah, S, Dudziec, E, Drayton, R M, Zlotta, A R, Morgan, S L, Rosario, D J, Hamdy, F C, Catto, J W F

“…Background: Urinary biomarkers are needed to improve the care and reduce the cost of managing bladder cancer. Current biomarkers struggle to identify both high…”
Get full text

Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder by Hermanns, T, Bhindi, B, Wei, Y, Yu, J, Noon, A P, Richard, P O, Bhatt, J R, Almatar, A, Jewett, M A S, Fleshner, N E, Zlotta, A R, Templeton, A J, Kulkarni, G S

“…Background: An elevated neutrophil-to-lymphocyte ratio (NLR) is associated with poor outcome in various tumours. Its prognostic utility in patients with…”
Get full text

Extraperitoneal laparoscopic radical prostatectomy. Results after 50 cases by Bollens, R, Vanden Bossche, M, Roumeguere, T, Damoun, A, Ekane, S, Hoffmann, P, Zlotta, A R, Schulman, C C

“…After an initial experience using transperitoneal laparoscopic radical prostatectomy as described by Vallancien and Guillonneau, we developed a pure…”
Get more information

Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction by Zlotta, A R, Djavan, B, Marberger, M, Schulman, C C

“…Use of prostate specific antigen (PSA) density to enhance the predictive value of detecting prostate cancer at intermediate PSA levels has been limited due to…”
Get more information

Nutrition and prostate cancer: evidence or suspicion? by Schulman, C.C, Ekane, S, Zlotta, A.R

Get full text

Current status of minimally invasive treatment options for localized prostate carcinoma by Beerlage, H P, Thüroff, S, Madersbacher, S, Zlotta, A R, Aus, G, de Reijke, T M, de la Rosette, J J

“…Prostate cancer is the leading malignancy in men today and an increase in detected localized prostate cancers is expected in the years to come. Even though…”
Get more information

Prostate specific antigen density of the transition zone for early detection of prostate cancer by Djavan, B, Zlotta, A R, Byttebier, G, Shariat, S, Omar, M, Schulman, C C, Marberger, M

“…We compare the ability of several prostate specific antigen (PSA) parameters, including PSA density of the whole prostate and of the transition zone, percent…”
Get more information

Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study by Zlotta, A R, Raviv, G, Peny, M O, Noel, J C, Haot, J, Schulman, C C

“…Transurethral needle ablation of benign prostatic hypertrophy (BPH) is a rapid, anesthesia-free outpatient procedure using low level radiofrequency energy that…”
Get more information

Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yield by Djavan, B, Zlotta, A R, Ekane, S, Remzi, M, Kramer, G, Roumeguère, T, Etemad, M, Wolfram, R, Schulman, C C, Marberger, M

“…Although the sextant biopsy technique has been widely used, concern has arisen that this method may not include an adequate sampling of the prostate,…”
Get more information

BPH and sexuality by Zlotta, A R, Schulman, C C

“…Quality of life has become a very important parameter in benign prostatic hyperplasia (BPH) and one of the major concepts identified by the patients to be…”
Get more information

An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less by Zlotta, Alexandre R, Remzi, Mesut, Snow, Peter B, Schulman, Claude C, Marberger, Michael, Djavan, Bob

“…An artificial neural network was developed to improve the prediction of pathological stage before radical prostatectomy based on variables available at biopsy…”
Get more information

The importance of measuring the prostatic transition zone: an anatomical and radiological study by ZLOTTA, A. R, DJAVAN, B, DAMOUN, M, ROUMEGUERE, T, PETEIN, M, ENTEZARI, K, MARBERGER, M, SCHULMAN, C. C

“…Objective  To assess the accuracy and reliability of measurements of the volume of the transition zone (TZ, representing the hypertrophied benign component)…”
Get full text

What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary? by Zlotta, A R, van Vooren, J P, Huygen, K, Drowart, A, Decock, M, Pirson, M, Jurion, F, Palfliet, K, Denis, O, Simon, J, Schulman, C C

“…For more than 20 years, BCG intravesical therapy schedule has included 6 weekly instillations. Very few studies have, however, analyzed the rationale of this…”
Get more information

Clinical evolution of prostatic intraepithelial neoplasia by Zlotta, A R, Schulman, C C

“…High-grade prostatic intraepithelial neoplasia (PIN) is most likely a precursor of prostate cancer and is frequently associated with it whereas the direct link…”
Get more information

Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml by Zlotta, A R, Djavan, B, Petein, M, Susani, M, Marberger, M, Schulman, C C

“…Prostate specific antigen (PSA) density of the transition zone, which is the density of serum PSA related to the volume of the transition zone, has been…”
Get more information

Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early clinical experience by Schulman, Claude C., Zlotta, Alexandre R.

“…Many attempts have been made to develop a method for treatment of benign prostatic hyperplasia (BPH) that is minimally invasive, efficacious, and low-cost…”
Get full text

Treatment options after failure of local curative treatments in prostate cancer: a controversial issue by Schulman, C.C., Altwein, J.E., Zlotta, A.R.

Get full text

Non-muscle invasive bladder cancer recurrences in patients managed with trimodal therapy: Conservative or radical treatment? by Ajib, K.A., Berjaoui, M.B., Caceres, J.O.H., Tjong, M.C., Nason, G., Erlich, A., Sridhar, S., Fleshner, N.E., R. Zlotta, A., Catton, C., Berlin, A., Chung, P., Kulkarni, G.S.

Get full text

Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer by ZLOTTA, A. R, DJAVAN, B, MATOS, C, NOEL, J.-C, PENY, M.-O, SILVERMAN, D. E, MARBERGER, M, SCHULMAN, C. C

“…Objective  To evaluate the safety of radiofrequency (RF) energy delivered interstitially in patients with prostate cancer scheduled for radical prostatectomy…”
Get full text

Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette–Guérin (BCG) in patients with superficial bladder cancer by ZLOTTA, A. R., DROWART, A., HUYGEN, K., DE BRUYN, J., SHEKARSARAI, H., DECOCK, M., PIRSON, M., JURION, F., PALFLIET, K., DENIS, O., MASCART, F., SIMON, J., SCHULMAN, C. C., VAN VOOREN, J. P.

“…Few studies have analysed the antibody response during intravesical BCG immunotherapy for superficial bladder cancer. We have examined the evolution in serum…”
Get full text